Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases.
Crohn disease
inflammatory bowel diseases
spondyloarthritis
ulcerative colitis
Journal
The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
accepted:
03
07
2020
pubmed:
17
7
2020
medline:
1
9
2021
entrez:
17
7
2020
Statut:
ppublish
Résumé
Spondyloarthritis (SpA) is among the most frequent extraintestinal manifestations of inflammatory bowel diseases (IBD). In this study, we aimed to validate the DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire in a multicenter cohort of patients with IBD enrolled at 11 gastroenterology units. From October 2018 to March 2019, consecutive adult patients with IBD, either Crohn disease or ulcerative colitis, independently filled out the DETAIL questionnaire in the outpatient waiting room. Within 2 weeks a blinded rheumatologist assessed all the patients, irrespective of the DETAIL results, and classified them to be affected or not by SpA. The performance of the questions was evaluated through Bayesian analysis. Overall, 418 patients with IBD filled out the DETAIL questionnaire. Upon rheumatological evaluation, 102 (24.4%) patients received a diagnosis of SpA. Of the 6 questions, the best performances were found in question 6 [positive likelihood ratio (LR)+ 3.77], reporting inflammatory back pain at night, and in question 3 (LR+ 3.31), exploring Achilles enthesitis. The presence of back pain lasting > 3 months (LR+ 2.91), back pain with inflammatory features (LR+ 2.55), and a history of dactylitis (LR+ 2.55), also showed a fairly good performance, whereas a history of peripheral synovitis was slightly worse (LR+ 2.16). The combination of at least 3 questions answered affirmatively yielded a posttest probability of SpA of 80% or more. The presence of alternative diagnoses, such as osteoarthritis or fibromyalgia, represented a minor confounder. The DETAIL questionnaire is a useful tool for the early detection of SpA in IBD.
Identifiants
pubmed: 32669448
pii: jrheum.200364
doi: 10.3899/jrheum.200364
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
179-187Investigateurs
Valentina Marconi
(V)
Lucia Perini
(L)
Valentino Paci
(V)
Monia Ciferri
(M)
Laura Bolognini
(L)
Antonio Di Sario
(A)
Emanuele Bendia
(E)
Piergiorgio Mosca
(P)
Davide Giuseppe Ribaldone
(DG)
Maria Chiara Ditto
(MC)
Viktoriya Pavlych
(V)
Angelo Viscido
(A)
Gianpiero Stefanelli
(G)
Paola Conigliaro
(P)
Livia Biancone
(L)
Pamela Polito
(P)
Renata D'Inca
(R)
Luca Navarini
(L)
Paola Balestrieri
(P)
Mariaelena Serio
(M)
Stefania Maltoni
(S)
Antonella Scarcelli
(A)
Rita Girolimetti
(R)
Gabriele Frausini
(G)
Flavia Baccini
(F)
Paola Tomietto
(P)
Cinzia Tonello
(C)
Marco Fiorani
(M)
Rebecca Marcasciano
(R)
Informations de copyright
Copyright © 2021 by the Journal of Rheumatology.